Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emerging BioCommunications
Watertown, Massachusetts, United Stateslinkedin.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Emerging BioCommunications was a boutique public relations firm specializing in strategic communications for life sciences, biotech, and healthcare companies. The firm was acquired by Slowey McManus Communications in January 2022. Its founder, Jeff Krasner—a former journalist with extensive experience covering biotechnology—joined SMC as Senior Vice President and Leader of the Life Sciences Group. The acquisition expanded SMC’s client base to include more early- and clinical-stage life science firms.
- Industry
- Consulting
Beyond the preview
Go deeper on Emerging BioCommunications.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emerging BioCommunications.